Norethindrone Acetate and Ethinyl Estradiol (Nivagen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Norethindrone Acetate and Ethinyl Estradiol drug offered from Nivagen Pharmaceuticals, Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nivagen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Norethindrone Acetate and Ethinyl Estradiol |
SUBSTANCE NAME: | NORETHINDRONE ACETATE; ETHINYL ESTRADIOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-11-25 |
END MARKETING DATE: | 0000-00-00 |
Norethindrone Acetate and Ethinyl Estradiol HUMAN PRESCRIPTION DRUG Details:
Item Description | Norethindrone Acetate and Ethinyl Estradiol from Nivagen Pharmaceuticals, Inc. |
LABELER NAME: | Nivagen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .5; .0025(mg/1; mg/1) |
START MARKETING DATE: | 2016-11-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 75834-129_2a5bf7b7-2dad-4e30-8934-3a9af468b630 |
PRODUCT NDC: | 75834-129 |
APPLICATION NUMBER: | ANDA203435 |
Other NORETHINDRONE ACETATE; ETHINYL ESTRADIOL Pharmaceutical Manufacturers / Labelers: